Harel Insurance Investments & Financial Services Ltd.
InsurancePosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1429390
Ramat Gan, L3
Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,759,629
+$133,995 QoQ
Shares Held
2,822
+34.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#541
of 1,322 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Harel Insurance Investments & Financial Services Ltd. holds $5,070,384 across 6 Biotechnology names. REGN ranks #2 (34.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,837 | $1,905,953 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,822 | $1,759,629 | |
| 3 | EXEL |
Exelixis, Inc.
|
16,890 | $918,984 | |
| 4 | INCY |
Incyte Corp
|
3,670 | $416,031 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
1,550 | $53,196 | |
| 6 | CAPR |
Capricor Therapeutics, Inc.
|
689 | $16,591 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,759,629 | 2,822 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,625,634 | 2,104 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,648,714 | 2,136 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $1,108,796 | 1,972 | Shares | Defined | 2025-10-29 | |
| 2025-06-30 | $597,450 | 1,138 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $407,809 | 643 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $452,329 | 635 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $692,767 | 659 | Shares | Defined | 2024-10-15 | |
| 2024-06-30 | $413,054 | 393 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $656,418 | 682 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $281,052 | 320 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $595,000 | 723 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $252,207 | 351 | Shares | Defined | 2023-07-17 | |
| 2023-03-31 | $2,994,987 | 3,645 | Shares | Defined | 2023-05-02 | |
| 2022-12-31 | $4,316,674 | 5,983 | Shares | Defined | 2023-01-26 | |
| 2022-09-30 | $1,870,282 | 2,715 | Shares | Defined | 2022-10-31 | |
| 2022-06-30 | $1,153,294 | 1,951 | Shares | Defined | 2022-07-19 | |
| 2022-03-31 | $41,905 | 60 | Shares | Defined | 2022-05-03 | |
| 2021-12-31 | $1,564,906 | 2,478 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $225,126 | 372 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $1,247,219 | 2,233 | Shares | Defined | 2021-07-26 | |
| 2021-03-31 | $532,755 | 1,126 | Shares | Defined | 2021-04-27 | |
| 2020-12-31 | $791,334 | 1,638 | Shares | Defined | 2021-01-26 | |
| 2020-09-30 | $843,588 | 1,507 | Shares | Defined | 2020-10-20 | |
| 2020-03-31 | $313,970 | 643 | Shares | Defined | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||